Sectoral Asset Management’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Sectoral Asset Management’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-123,405	Closed	-$1.38M	–	162
2018 Q3	$1.38M	Buy	123,405 +11,192	+10%	+$118K	0.15%	66
2018 Q2	$1.48M	Hold	112,213	–	–	0.17%	63
2018 Q1	$1.7M	Buy	112,213 +36,900	+49%	+$600K	0.19%	65
2017 Q4	$1.43M	Buy	75,313 +45,000	+148%	+$753K	0.18%	64
2017 Q3	$512K	Buy	+30,313	New	+$495K	0.07%	61

Other funds holding CMTA

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Sectoral Asset Management's CMTA Position: Q4 2018 in Review

Sectoral Asset Management sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q4 2018, closing a stake of 123,405 shares — an estimated $1.38M sold.

Sectoral Asset Management first reported a position in CMTA in Q3 2017 and held it in 5 quarters. The position peaked at $1.7M in Q1 2018. 31 funds tracked by Wall St. Rank hold CMTA as of Q4 2018.

Sectoral Asset Management reported no remaining Clementia Pharmaceuticals Inc. position as of Q4 2018 after selling out during the quarter.
Sectoral Asset Management sold 123,405 Clementia Pharmaceuticals Inc. shares in Q4 2018, an estimated $1.38M.
Sectoral Asset Management first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 5 quarters.
Sectoral Asset Management's Clementia Pharmaceuticals Inc. position peaked at $1.7M in Q1 2018.
31 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q4 2018.

Based on Sectoral Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.